Macrogol 4000 Sandoz

Quick links

Choose a section

Quick links to important sections

Advertisements

Macrogol 4000 Sandoz

Advertisements
Advertisements

Method of action: Laxative

Treatment option:

Advertisements

Overview of Macrogol 4000 Sandoz

Quick Facts

Property Description
Active ingredient Macrogol 4000 (Polyethylene Glycol 4000)
Form Powder for oral solution, typically in sachets
Pharmacological class Osmotic laxative
Common purpose To normalize the consistency and passage of stool
Origin Synthetic polymer

What is Macrogol 4000 Sandoz and What Type of Drug is it?

Macrogol 4000 Sandoz is a recognized medicinal product whose active component is Macrogol 4000, also known as Polyethylene Glycol 4000 (PEG 4000). It is formally classified as an osmotic laxative, a drug category whose efficacy in managing issues of infrequent bowel movements is clinically recognized. Macrogol 4000's primary function is to achieve high water retention in the colon, thereby treating difficulty in passing stools. This means the medicine helps to gently correct the movement of the bowels by making the contents easier to pass. The active substance is an inert, synthetic polymer characterized by its high molecular weight.


The Composition and Form of Macrogol 4000 Sandoz

This product, marketed by Sandoz, is a single active ingredient preparation, supplied exclusively as a powder for oral solution, commonly packaged in individual sachets. This presentation requires complete dissolution in an aqueous medium, such as water, by the user prior to its oral administration. Polyethylene Glycol is minimally absorbed from the gastrointestinal tract, confining its activity entirely to the digestive lumen. This assures patients that the active component works locally where needed and is not taken up systemically.


The General Therapeutic Purpose of Osmotic Laxatives

The general purpose of this medication is to restore comfortable and regular intestinal transit by normalizing the stool's physical properties. By remaining unabsorbed within the digestive tract, the Macrogol 4000 attracts and holds water via osmosis, thereby softening the fecal mass and increasing its bulk. This approach provides a predictable method for managing issues related to stool hardness and passage, differentiating it from stimulant laxatives that rely on chemical signaling. Its function is commonly utilized in a neutral scenario, such as relieving temporary constipation associated with travel or dietary changes.

Advertisements

What side effects are possible with Macrogol 4000 Sandoz?

Possible Side Effects and Safety Information

The safety profile for Macrogol 4000 Sandoz is based on officially documented adverse reactions categorized by their frequency in clinical and post-marketing settings. It is important to note that this information addresses the risk profile, not therapeutic benefits.


Frequency-Classified Adverse Reactions

Adverse reactions are officially classified according to their frequency. The most commonly reported events are generally related to the gastrointestinal system and may occur particularly at the beginning of treatment.

Frequency Classification Examples of Documented Reactions
Common (up to 1 in 10 patients) Abdominal pain, abdominal bloating (distension), diarrhea, nausea (Adults)
Uncommon (up to 1 in 100 patients) Vomiting, urge to defecate, fecal incontinence (Adults)
Not Known (Frequency cannot be estimated) Anaphylactic shock, angioedema (swelling of the face or throat), rash, urticaria (hives)

Serious and Clinically Significant Safety Concerns

Although rare and classified as Not Known frequency, serious hypersensitivity reactions have been documented, including anaphylactic shock and angioedema, which require immediate attention.

The medicine's safety profile also includes a documented risk of electrolyte disturbances, specifically low blood sodium (hyponatremia) and low blood potassium (hypokalaemia). This risk is a particular consideration for elderly patients or those with impaired renal or hepatic function, or those using diuretics, especially if they experience severe diarrhea.

Safety-Related Restrictions (Contraindications)

Macrogol 4000 Sandoz must not be used in patients with specific pre-existing conditions. These regulatory contraindications include:

  • Severe inflammatory bowel disease (e.g., Crohn's disease, ulcerative colitis, toxic megacolon).
  • Existing or suspected intestinal obstruction.
  • Intestinal perforation or a high risk of perforation.
  • Known hypersensitivity to Macrogol 4000 or any of the product's excipients.

These strict limitations are imposed to prevent the risk of severe complications under specific physiological conditions.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

This section outlines the officially documented clinical manifestations of Macrogol 4000 overdose and the required emergency actions as described in regulatory prescribing information.

Overdose with Macrogol 4000 may manifest through severe exaggeration of its effects, primarily involving the gastrointestinal system. Documented overdose presentations include diarrhoea, abdominal pain, vomiting, and abdominal distension.


Documented Severe Outcomes and Emergency Actions

Domain Official Regulatory Statement
Serious Outcomes Severe fluid loss may lead to dehydration and serious electrolyte disturbances, specifically Hyponatraemia (low sodium) and Hypokalaemia (low potassium).
Urgent Action Required Contact a doctor as soon as possible for severe diarrhoea or vomiting. Seek immediate medical attention for signs of a severe allergic reaction, such as breathing difficulties or collapse.
Antidote Status No specific antidote is known.
Management Measures Management involves symptomatic treatment, temporary interruption of treatment, or a dosage reduction. Correction of electrolyte disturbances may be required in severe cases.
Vulnerable Populations Electrolyte monitoring is required, especially for the elderly and those with impaired renal or hepatic function when severe fluid loss occurs.

The regulatory profile dictates that the most critical risk is electrolyte imbalance resulting from severe fluid loss. Mandated help-seeking conditions are directly tied to the severity of this fluid loss, requiring contact with a medical professional to prevent serious salt depletion.

Advertisements

Therapeutic Uses of Macrogol 4000 Sandoz

Macrogol 4000 Sandoz is considered relevant in contexts marked by increased discomfort or tension, specifically addressing symptoms related to physical discomfort associated with sluggish or difficult bowel movements. It is commonly used to help with the easing of the overall symptom burden, supporting stool passage and assisting with gut movement.

This medicine is generally used for the management of constipation, including chronic cases, and may assist with the resolution of faecal impaction. These are conditions presenting with systemic or localized discomfort that often involve recurrent or episodic manifestations (constipation, chronic cases, faecal impaction). The effect may be noticed gradually, providing supportive relief when symptoms that interfere with daily functioning become temporarily overwhelming.

This medication is applied in addressing clinical scenarios marked by temporary physiological imbalance. It contributes to improved comfort during periods of heightened symptoms, and supports patients during episodes of heightened discomfort. This may be part of symptomatic management across conditions characterized by periods of heightened symptoms to help maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Supports ease of symptoms related to physical discomfort

Regulatory References

  1. NIH StatPearls overview of Polyethylene Glycol
Advertisements

Eligibility and Restrictions for Use

This information details the specific populations permitted or prohibited from using Macrogol 4000 Sandoz, as defined by official regulatory documents.

Populations Permitted and Excluded

Classification Populations Covered
Allowed Adults and children aged mathbf8 years and above.
Not Recommended Children below 8 years of age (consult a doctor for specific pediatric preparations).
Caution/Special Consideration Patients with impaired renal or hepatic function; those who are elderly or taking diuretics (due to potential electrolyte disturbances).
Contraindicated (Must Not Use) Individuals with known hypersensitivity to macrogol (polyethylene glycol) or other product ingredients.
Contraindicated (Must Not Use) Patients with existing severe inflammatory bowel disease (such as ulcerative colitis or Crohn's disease), toxic megacolon, digestive perforation or risk of perforation, intestinal obstruction (ileus or symptomatic stenosis), or painful abdominal syndromes of indeterminate cause.

Age, Pregnancy, and Lactation Status

  • Age-Related Eligibility: The medicine is intended for adults and children ge 8 years for the 10g sachet/dose. Treatment in children should not exceed 3 months due to limited long-term data.
  • Pregnancy and Lactation: Macrogol 4000 can be used during pregnancy and whilst breast-feeding, as its systemic absorption is negligible. However, medical advice is recommended.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Macrogol 4000 Sandoz (Polyethylene Glycol 4000) is an osmotic laxative that is minimally absorbed into the bloodstream. Due to this non-systemic activity, the medicine is not documented to interact via Cytochrome P450 (CYP) metabolism or drug transporters, which are common pathways for many systemic drug interactions.


Pharmacokinetic and Absorption-Based Interactions

Its primary interaction mechanism is pharmacokinetic, resulting from the increase in gastrointestinal (GI) transit rate. Co-administration of Macrogol 4000 may cause a transient reduction in the intestinal absorption and subsequent decreased efficacy of other oral medicinal products.

This interaction is considered most significant for medicines with a Narrow Therapeutic Index (NTI), where small changes in concentration can alter therapeutic effect. Specific substances noted in regulatory documents whose absorption may be affected include Digoxin, certain Antiepileptics (e.g., Phenytoin), Coumarins, and Immunosuppressive Agents.


Physical and Pharmacodynamic Constraints

  • Mandatory Restriction: This product must not be directly mixed with starch-based thickeners (used for patients with swallowing difficulties or dysphagia). This combination results in a physical interaction that counteracts the thickening action, creating a thin, watery liquid, which significantly increases the risk of aspiration for vulnerable patients.
  • Additive Effect: Co-administration with Diuretics (water tablets) in elderly patients is noted to increase the risk of fluid and electrolyte disturbances (e.g., low sodium or potassium levels) if Macrogol 4000 causes diarrhea.
Advertisements

Mechanism of Action

How Macrogol 4000 Sandoz Works

Osmotic Retention and Physicochemical Action

Macrogol 4000's action is fundamentally physicochemical, centered on osmotic retention within the intestinal lumen. The polymer is pharmacologically inert and does not engage with biological targets like receptors, enzymes, or ion channels. Instead, it creates a powerful osmotic gradient that draws and binds water molecules into the colon. This mechanism primarily focuses on modulating local fluid dynamics and fecal rheology, and does not engage molecular signaling pathways.

Bulk Volume and Secondary Motility Activation

The water binding and retention result in a highly hydrated fecal mass, increasing the volume and altering the rheological properties of the intestinal contents. This mechanical change—the physical stretching of the colonic wall by the enlarged, softened mass—is the trigger for the secondary activation of the peristaltic reflex within the colon. This reflexive smooth muscle contraction is indirect, resulting in the movement of the contents forward within the large intestine.

Advertisements

Dosage and Administration Information

How Macrogol 4000 Sandoz is used

Macrogol 4000 Sandoz is a powder for oral solution, and its administration is strictly governed by regulatory guidelines to ensure proper use. The active ingredient, Macrogol 4000 (Polyethylene Glycol), is only intended for oral use after being prepared as a liquid.

Official Dosing and Administration

The standard approach to using the medicine is defined by specific dosage ranges, frequency, and preparation requirements detailed in prescribing information.

Usage Aspect Official Instruction
Dosing (Adults/Adolescents 8 years) 10 g to 20 g of Macrogol 4000 per day (typically one to two sachets). The dose is adjusted according to the effect.
Frequency and Timing The dose is taken once daily, preferably as a single administration in the morning, and can be taken with or without food.
Preparation Each sachet must be fully dissolved in a glass of water (approximately 125 mL) immediately prior to administration. The solution is then consumed by mouth.

Duration and Special Usage Rules

The official instructions establish time limits on how long the medicine is typically used. For routine management, the period of use should not normally exceed two weeks, although continued use may be recommended under medical supervision for chronic needs. In children aged eight years and above, the maximum period of continuous administration is three months, due to a lack of longer-term clinical data in this population.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Macrogol 4000 Sandoz

Evidence for Use in Chronic Constipation and Bowel Function

Clinical research for Macrogol 4000 (PEG 4000) primarily consists of Randomized Controlled Trials (RCTs) and meta-analyses that explored outcomes related to chronic difficulty in passing stools. Studies monitored measurements like changes in the frequency of bowel movements per week and alterations in stool consistency, often comparing Macrogol 4000 to placebo. Trials reported patterns of change in these measurements across diverse adult and pediatric populations. However, the existing research base largely consists of short-term studies, and long-term outcomes are not well characterized.


Research on Faecal Impaction Resolution

Macrogol 4000 was evaluated in research exploring acute episodes such as faecal impaction, primarily focusing on children. Studies monitored outcomes related to physiological strain and examined the successful clearance rate of the colon. Scientific reviews report the evidence level is generally Moderate for this acute indication. Uncertainty remains because comparative evidence is lacking for certain groups, and much of the literature examined PEG formulations that included electrolytes.


Evidence in Specific Patient Populations

Research has examined patient-reported experiences in specific groups, including children (aged ≥ six months) and, to a limited extent, older adults and the elderly. Additionally, some small comparative studies have monitored pregnant women. Overall, results apply only to the specific populations studied, as the sample sizes for these unique subgroups were often modest, leading to insufficient data for certain groups.


Long-Term Data and Follow-Up in Clinical Trials

Research explored the effects of Macrogol 4000 over defined time intervals, from short-term (up to four weeks) to intermediate-term follow-up (up to three to six months). Research describes findings related to measured outcomes observed over these defined intermediate time periods. However, there is limited information for long-term outcomes that describe use extending beyond one year, meaning long-term effects are not fully established.


What Remains Uncertain in the Research Landscape

The evidence highlights the presence of variability of findings (heterogeneity) reported in some systematic reviews, indicating the specific results were mixed across trials. Additionally, comparative evidence is lacking in certain complex subgroups, and findings were mixed regarding the consistency of observed patterns over very long follow-up durations. Research provides context but does not determine whether an individual will respond similarly.

Key Studies & References

  1. Polyethylene Glycol (Macrogol) for Constipation Overview - NIH StatPearls
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Macrogol 4000 Sandoz (FAQ)


Q: How quickly can someone expect Macrogol 4000 Sandoz to start working?

According to official product information, the effect of Macrogol 4000 is generally observed gradually. Patients can typically expect the medicine to begin working within 24 to 48 hours after the first administration.


Q: Can Macrogol 4000 Sandoz be taken long term, or is it only for a short time?

Regulatory documents indicate that for the routine management of difficulty in passing stools, the period of use should not normally exceed two weeks for adults. For chronic needs, official information notes that continued use may be monitored under medical supervision. In children, official guidance limits continuous administration to a maximum of three months due to limited long-term data in that age group.


Q: Is it normal to experience bloating or gas when first starting Macrogol 4000 Sandoz?

Yes, official safety information classifies abdominal bloating and abdominal pain as Common side effects, a classification used for events observed in up to 1 in 10 patients in clinical settings. These gastrointestinal effects are generally related to the start of treatment, as the medicine begins to work. Patients may also experience mild wind or flatulence.


Q: What kind of research has been done on the long-term use of Macrogol 4000?

Clinical research has primarily been conducted over short-term (up to four weeks) to intermediate-term (up to six months) follow-up periods. Regulatory documents state that there is limited information for long-term outcomes extending beyond one year, indicating that long-term effects are not fully established in the research literature.


Q: What interactions are described in official documents regarding Macrogol 4000 Sandoz and other oral medicines?

The primary interaction mechanism is physicochemical, meaning it works physically in the gut. The medicine may cause a transient reduction in the intestinal absorption of other oral medicinal products taken at the same time due to an increase in intestinal transit rate. Specific substances noted in regulatory documents include medicines with a Narrow Therapeutic Index, such as Digoxin or certain antiepileptic drugs.


Q: Can Macrogol 4000 Sandoz affect the absorption of vitamins or supplements?

Official information indicates that the medicine may reduce the absorption of oral medicinal products. While vitamins and supplements are not always classified as medicinal products, a reduction in the absorption of certain orally administered substances may potentially occur. Official information indicates that vitamins and supplements should be discussed with a healthcare professional.


Q: What does official guidance say about stopping Macrogol 4000 Sandoz after symptom relief?

Official guidance often establishes time limits for use, such as not normally exceeding two weeks for routine adult use, suggesting discontinuation when symptoms are resolved. For children, the objective is to maintain relief using lifestyle and dietary measures after stopping the medicine. Any changes to the regimen are generally made under the guidance of a health professional.


Q: What should a patient expect regarding the consistency of bowel movements while taking this medicine?

Macrogol 4000 works by attracting and holding water to soften the fecal mass and increase its bulk. If diarrhoea occurs (a Common side effect), this may be a factor to discuss regarding dose adjustment.


Q: Why do some people experience mild nausea after taking Macrogol 4000 Sandoz?

Nausea is classified in official documents as a Common, generally mild and transitory adverse reaction. Like other common side effects, it is a gastrointestinal symptom that typically concerns the digestive system and may be more noticeable at the beginning of treatment.


Q: Is Macrogol 4000 Sandoz safe for people with kidney problems?

Regulatory documents advise that use requires caution in patients with impaired renal (kidney) function. This is primarily because if diarrhoea occurs, there is an increased risk of disturbances to the body's water and electrolyte balance. In these situations, professional electrolyte monitoring is a consideration.


Q: Can Macrogol 4000 Sandoz cause mineral or electrolyte imbalances?

Yes, official safety documents list Electrolyte disorders, specifically low blood sodium (Hyponatremia) and low blood potassium (Hypokalaemia), as a documented risk. This risk is a particular concern if a patient experiences severe diarrhoea, especially among elderly individuals or those taking diuretics.


Q: Is it necessary to take Macrogol 4000 Sandoz at a specific time of day?

The regulatory instructions state that the dose is to be taken once daily. It is preferably taken as a single administration in the morning.


Q: Is Macrogol 4000 Sandoz absorbed into the body or does it pass through?

Official pharmacokinetic properties confirm that Macrogol 4000 is an inert substance that is not absorbed into the bloodstream or broken down in the body. Its action is confined entirely to the digestive tract, meaning the active component passes through the system.


Q: Do you need a prescription to get Macrogol 4000 Sandoz?

The medicine's dispensing status can vary by region. In some countries, Macrogol 4000 preparations are available over-the-counter (OTC), while in others, they may be classified as prescription-only medicine (Rx).


Q: Does Macrogol 4000 Sandoz have any taste or flavor?

According to the product’s excipient list, Macrogol 4000 Sandoz powder typically contains a flavouring. This is usually described as an orange-grapefruit flavour.


Q: Are there specific food or drink types that should be avoided when taking this medicine?

A mandatory restriction specified in regulatory documents is that the product must not be directly mixed with starch-based thickeners used for swallowing difficulties. This physical interaction can lead to a thin liquid, increasing the risk of aspiration for vulnerable patients.


Q: Can Macrogol 4000 Sandoz cause dehydration?

In official safety documents, dehydration is noted as a possibility in cases of severe or persistent diarrhoea, particularly in vulnerable groups like elderly patients. Official guidance notes that maintaining hydration is important when using this medicine.


Q: What are the ingredients in Macrogol 4000 Sandoz besides Macrogol 4000?

The active substance is Macrogol 4000. The regulatory list of other ingredients, known as excipients, includes the sweetener Sodium saccharin (E954), the sugar Sorbitol (E420), and a specified orange-grapefruit flavour.


Q: Does the powder dissolve completely in liquid?

Official administration instructions specify that the powder must be fully dissolved in the designated amount of liquid before being taken. The resulting solution is expected to be clear and transparent.


Q: If I skip a day, should I take double the amount the next day?

Patient information suggests taking the missed dose as soon as it is remembered. However, it is explicitly stated in official information that a patient should not take a double dose to compensate for the forgotten dose.


Q: How does Macrogol 4000 Sandoz compare to a stimulant laxative?

Macrogol 4000 is classified as an osmotic laxative, which physically works by drawing and holding water in the bowel to soften and hydrate the stool. This differs from a stimulant laxative, which works by chemically stimulating the nerves that control the gut muscles to force movement.


Q: What is the meaning of 'Macrogol 4000' in the drug name?

Macrogol is the name given to the compound Polyethylene Glycol (PEG). The number 4000 indicates the average molecular weight of the polymer chain. This high molecular weight is the characteristic that prevents the substance from being absorbed by the body.


Q: Can Macrogol 4000 Sandoz cause stomach pain or cramps?

Abdominal pain is listed in official documentation as a Common side effect. While the medicine is generally not intended to cause strong cramping or painful urgency, feelings of stomach discomfort are possible.


Q: Does Macrogol 4000 Sandoz require drinking extra water throughout the day?

The powder must be dissolved in a specified amount of water before consumption. Additionally, official guidance recommends drinking sufficient water intake throughout the day when addressing constipation, especially since diarrhoea can sometimes occur with this type of medicine.


Q: How long after mixing the solution does it stay good to drink?

Official storage instructions state that once the powder is dissolved, the resulting solution may be stored in a refrigerator at a temperature between 2 C and 8 C for a maximum of 24 hours.


Q: Are allergic reactions to Macrogol 4000 Sandoz common?

Serious hypersensitivity reactions—such as swelling of the face (angioedema), rash, or anaphylactic shock—have been documented. However, their frequency is officially classified as Not Known, meaning they cannot be estimated from the available data, which suggests they are rare occurrences.


Q: Is Macrogol 4000 Sandoz gluten-free or suitable for people with Celiac disease?

Based on the product composition and excipients, Macrogol 4000 is generally considered to be gluten-free. This means the formulation is suitable for use by people with Celiac disease or those adhering to a gluten-free diet.


Q: Does the medicine contain any sugar or sweeteners?

Yes, official documents indicate the product contains the sweetener Sodium saccharin (E954). It also contains the sugar alcohol sorbitol (E420), which is listed as an excipient.


Q: Can Macrogol 4000 Sandoz be used by people with diabetes?

Official patient leaflets indicate that Macrogol 4000 Sandoz may nevertheless be used if you are diabetic. This is because the product contains only a small amount of sorbitol.


Q: Can taking Macrogol 4000 Sandoz with food impact how it works?

The official administration instructions state that the medicine can be taken with or without food. This indicates that the presence of food does not significantly impact the medicine's physicochemical mode of action in the intestinal tract.


Q: Are there any documented interactions between Macrogol 4000 Sandoz and common pain relievers?

Macrogol 4000 can cause a transient reduction in the intestinal absorption of oral medicinal products due to its action on the gut transit rate. While common pain relievers are not specifically identified among the high-risk drugs, consultation with a doctor or pharmacist is recommended when taking any other oral medicine.

Advertisements

How should Macrogol 4000 Sandoz be stored and disposed of?

How to Store and Dispose of Macrogol 4000 Sandoz

Official regulatory documents define specific conditions for storing and disposing of this product to ensure both medicine quality and environmental safety.


Storage Conditions

  • Unused Powder: The Macrogol 4000 Sandoz powder must be stored out of the sight and reach of children and must not be stored above 25 °C. It should be kept in the original sachet until use and not used past the expiry date.
  • Prepared Solution: Once the powder is dissolved, the resulting solution may be stored in a refrigerator (between 2 °C and 8 °C) for a maximum of 24 hours.

Disposal Instructions

Expired or unused Macrogol 4000 Sandoz must not be disposed of in household waste or wastewater. Patients should return the unused medicine to a pharmacist, who is authorized to manage pharmaceutical waste to help protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Macrogol 4000 Sandoz found in:

A-Z Index: